Given that EZH2 is the enzymatic unit of PRC2 and the catalytic activity of PRC2 is dependent on the interaction between EZH2 and EED, we here investigated whether disruption of PRC2 by inhibiting EED would affect renal function and pathological changes in a murine model of cisplatin‐induced AKI. Here, EED is linked to acute kidney injury.